N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19) and can be associated with serious complications, including acute respiratory distress syndrome. This condition is accompanied by a massive release of cytokines, also denominated cytokin...

Descripción completa

Detalles Bibliográficos
Autores principales: Izquierdo-Alonso, José Luis, Pérez-Rial, Sandra, Rivera, Carolina Gotera, Peces-Barba, Germán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651994/
https://www.ncbi.nlm.nih.gov/pubmed/36410267
http://dx.doi.org/10.1016/j.jiph.2022.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651994/
https://www.ncbi.nlm.nih.gov/pubmed/36410267
http://dx.doi.org/10.1016/j.jiph.2022.11.009

Ejemplares similares